Glycogen Storage Disease Type II (GSD II) Completed Phase 1 Trials for Avalglucosidase alfa (DB16099)
Also known as: Glycogen Storage Disease Type II GSD II / Glycogen Storage Disease Type II (GSD-II)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0041318 (Glycogen Storage Disease Type II (GSD II)) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01898364 | Safety and Efficacy Evaluation of Repeat neoGAA Dosing in Late Onset Pompe Disease Patients. | Treatment |